Full View

Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS‐CoV‐2

R Lázaro‐Gorines, P Pérez, I Heras‐Murillo… - Advanced …, 2023 - Wiley Online Library
Administration of neutralizing antibodies (nAbs) has proved to be effective by providing
immediate protection against SARS‐CoV‐2. However, dual strategies combining virus …
被引用次数：1 相关文章

Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

R Lázaro-Gorines, P Pérez, I Heras-Murillo… - Advanced …, 2023 - search.proquest.com
Administration of neutralizing antibodies (nAbs) has proved to be effective by providing
immediate protection against SARS-CoV-2. However, dual strategies combining virus …

Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

R Lázaro-Gorines, P Pérez, I Heras-Murillo… - Advanced …, 2023 - pure.au.dk
Administration of neutralizing antibodies (nAbs) has proved to be effective by providing
immediate protection against SARS-CoV-2. However, dual strategies combining virus …
[PDF] scienceopen.com

[PDF][PDF] Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

R Lázaro-Gorines, P Pérez, I Heras-Murillo… - Adv. Sci, 2023 - scienceopen.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has given rise to one of the worst pandemics in recent history …
[HTML] nih.gov

[HTML][HTML] Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS‐CoV‐2

R Lázaro‐Gorines, P Pérez, I Heras‐Murillo… - Advanced …, 2023 - ncbi.nlm.nih.gov
Administration of neutralizing antibodies (nAbs) has proved to be effective by providing
immediate protection against SARS‐CoV‐2. However, dual strategies combining virus …

Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.

R Lázaro-Gorines, P Pérez, I Heras-Murillo… - Advanced Science …, 2023 - europepmc.org
Administration of neutralizing antibodies (nAbs) has proved to be effective by providing
immediate protection against SARS‐CoV‐2. However, dual strategies combining virus …
[PDF] core.ac.uk

[PDF][PDF] Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

R Lázaro-Gorines, P Pérez, I Heras-Murillo… - Adv. Sci, 2023 - core.ac.uk
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has given rise to one of the worst pandemics in recent history …

[引用][C] Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

R Lázaro-Gorines, P Pérez… - Advanced …, 2023 - produccioncientifica.ucm.es

Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

R Lázaro-Gorines, P Pérez, I Heras-Murillo… - 2023 - digital.csic.es
Administration of neutralizing antibodies (nAbs) has proved to be effective by providing
immediate protection against SARS-CoV-2. However, dual strategies combining virus …

Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

R Lázaro-Gorines, P Pérez… - Advanced science …, 2023 - pubmed.ncbi.nlm.nih.gov
Administration of neutralizing antibodies (nAbs) has proved to be effective by providing
immediate protection against SARS-CoV-2. However, dual strategies combining virus …